Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Gölz

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Diabetes Science and Technology|March 14, 2019
Time to Insulin Initiation in Type 2 Diabetes Patients in 2010/2011 and 2016/2017 in GermanyKarel Kostev, Stefan Gölz, Bernd-M Scholz, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 2, 2024
Safety and Effectiveness of Glargine 300 U/ml After Switching from Basal Insulins in Patients with Type 1 Diabetes: COMET-T StudyStefan Gölz, Julia K Mader, Stefan Bilz, et al.
BMJ Open Diabetes Research & Care|August 25, 2022
Controlling glycemic variability in people living with type 1 diabetes receiving insulin glargine 300 U/mL (Gla-300)Julia K Mader, Stefan Gölz, Stefan Bilz, et al.
Journal of the American Medical Directors Association|June 24, 2025
Pattern of Antidiabetic Drug Prescription in Older Persons With Type 2 Diabetes: Results From the German DPV RegistryAndrej Zeyfang, Stefan Gölz, Federica Iraci, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Diabetes Science and Technology|March 14, 2019
Time to Insulin Initiation in Type 2 Diabetes Patients in 2010/2011 and 2016/2017 in GermanyKarel Kostev, Stefan Gölz, Bernd-M Scholz, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 2, 2024
Safety and Effectiveness of Glargine 300 U/ml After Switching from Basal Insulins in Patients with Type 1 Diabetes: COMET-T StudyStefan Gölz, Julia K Mader, Stefan Bilz, et al.
BMJ Open Diabetes Research & Care|August 25, 2022
Controlling glycemic variability in people living with type 1 diabetes receiving insulin glargine 300 U/mL (Gla-300)Julia K Mader, Stefan Gölz, Stefan Bilz, et al.
Journal of the American Medical Directors Association|June 24, 2025
Pattern of Antidiabetic Drug Prescription in Older Persons With Type 2 Diabetes: Results From the German DPV RegistryAndrej Zeyfang, Stefan Gölz, Federica Iraci, et al.
Pageof 1